Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Macrogenics (MGNX) Non Operating Income (2016 - 2022)

Macrogenics (MGNX) has disclosed Non Operating Income for 11 consecutive years, with $819000.0 as the latest value for Q4 2022.

  • On a quarterly basis, Non Operating Income rose 282.71% to $819000.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $1.7 million, a 144.12% increase, with the full-year FY2025 number at $6.1 million, down 35.71% from a year prior.
  • Non Operating Income was $819000.0 for Q4 2022 at Macrogenics, up from $142000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $21.2 million in Q2 2019 to a low of -$6.7 million in Q3 2019.
  • A 5-year average of $1.4 million and a median of $384500.0 in 2020 define the central range for Non Operating Income.
  • Biggest YoY gain for Non Operating Income was 1881.5% in 2019; the steepest drop was 785.85% in 2019.
  • Macrogenics' Non Operating Income stood at -$3.0 million in 2018, then surged by 378.46% to $8.3 million in 2019, then tumbled by 99.0% to $83000.0 in 2020, then surged by 157.83% to $214000.0 in 2021, then surged by 282.71% to $819000.0 in 2022.
  • Per Business Quant, the three most recent readings for MGNX's Non Operating Income are $819000.0 (Q4 2022), $142000.0 (Q3 2022), and $504000.0 (Q2 2022).